Požymis
Inguinal hernia
Protrusion of the contents of the abdominal cavity through the inguinal canal.
Santrauka
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Inguinal hernia, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test339 genų susiję su Inguinal hernia
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Inguinal hernia. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| ABCD4ATP binding cassette subfamily D member 4 | Visada | 1 ligoje |
| ARID2AT-rich interaction domain 2 | Visada | 1 ligoje |
| ATAD1ATPase family AAA domain containing 1 | Visada | 1 ligoje |
| BRD4bromodomain containing 4 | Visada | 1 ligoje |
| CACHD1cache domain containing 1 | Visada | 1 ligoje |
| CIROZciliated left-right organizer protein containing ZP-N domains | Visada | 1 ligoje |
| COL3A1collagen type III alpha 1 chain | Visada | 1 ligoje |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Visada | 1 ligoje |
| DHRS3dehydrogenase/reductase 3 | Visada | 1 ligoje |
| DMRT2doublesex and mab-3 related transcription factor 2 | Visada | 1 ligoje |
| DNAJB4DnaJ heat shock protein family (Hsp40) member B4 | Visada | 1 ligoje |
| DSEdermatan sulfate epimerase | Visada | 2 ligose |
| EFEMP1EGF-like fibulin extracellular matrix protein 1 | Visada | 1 ligoje |
| EFEMP2EGF-like fibulin extracellular matrix protein 2 | Visada | 3 ligose |
| ERI1exoribonuclease 1 | Visada | 1 ligoje |
| FARSBphenylalanyl-tRNA synthetase subunit beta | Visada | 1 ligoje |
| FAT4FAT atypical cadherin 4 | Visada | 1 ligoje |
| FBXL4F-box and leucine rich repeat protein 4 | Visada | 1 ligoje |
| FIBPFGF1 intracellular binding protein | Visada | 2 ligose |
| GATA4GATA binding protein 4 | Visada | 1 ligoje |
| GNPATglyceronephosphate O-acyltransferase | Visada | 1 ligoje |
| IDUAalpha-L-iduronidase | Visada | 2 ligose |
| KDM2Blysine demethylase 2B | Visada | 1 ligoje |
| KDM6Blysine demethylase 6B | Visada | 1 ligoje |
| MAN2B2mannosidase alpha class 2B member 2 | Visada | 1 ligoje |
| MBTPS1membrane bound transcription factor peptidase, site 1 | Visada | 1 ligoje |
| MED16mediator complex subunit 16 | Visada | 1 ligoje |
| NDUFA8NADH:ubiquinone oxidoreductase subunit A8 | Visada | 1 ligoje |
| PAN2poly(A) specific ribonuclease subunit PAN2 | Visada | 1 ligoje |
| PIGQphosphatidylinositol glycan anchor biosynthesis class Q | Visada | 1 ligoje |
| PIGWphosphatidylinositol glycan anchor biosynthesis class W | Visada | 1 ligoje |
| POLR1ARNA polymerase I subunit A | Visada | 1 ligoje |
| PYCR1pyrroline-5-carboxylate reductase 1 | Visada | 2 ligose |
| SERPINH1serpin family H member 1 | Visada | 1 ligoje |
| SLC37A4solute carrier family 37 member 4 | Visada | 1 ligoje |
| SUPT7LSPT7 like, STAGA complex subunit gamma | Visada | 1 ligoje |
| TAF4TATA-box binding protein associated factor 4 | Visada | 1 ligoje |
| TGFBR1transforming growth factor beta receptor 1 | Visada | 2 ligose |
| TGFBR2transforming growth factor beta receptor 2 | Visada | 2 ligose |
| TMEM107transmembrane protein 107 | Visada | 1 ligoje |
Rodyti dar 299 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| TOR1Atorsin family 1 member A | Visada | 1 ligoje |
| UNC13Aunc-13 homolog A | Visada | 1 ligoje |
| WDR19WD repeat domain 19 | Visada | 1 ligoje |
| WDR35WD repeat domain 35 | Visada | 1 ligoje |
| AP1S2adaptor related protein complex 1 subunit sigma 2 | Labai dažnai (80–99%) | 1 ligoje |
| ATP6V0A2ATPase H+ transporting V0 subunit a2 | Labai dažnai (80–99%) | 4 ligose |
| ATP7AATPase copper transporting alpha | Labai dažnai (80–99%) | 2 ligose |
| CUL4Bcullin 4B | Labai dažnai (80–99%) | 1 ligoje |
| FLNAfilamin A | Labai dažnai (80–99%) | 1 ligoje |
| GUSBglucuronidase beta | Labai dažnai (80–99%) | 1 ligoje |
| IRX5iroquois homeobox 5 | Labai dažnai (80–99%) | 1 ligoje |
| PIK3R1phosphoinositide-3-kinase regulatory subunit 1 | Labai dažnai (80–99%) | 1 ligoje |
| SMCHD1structural maintenance of chromosomes flexible hinge domain containing 1 | Labai dažnai (80–99%) | 2 ligose |
| ADAMTS15ADAM metallopeptidase with thrombospondin type 1 motif 15 | Dažnai (30–79%) | 1 ligoje |
| AEBP1AE binding protein 1 | Dažnai (30–79%) | 2 ligose |
| AHDC1AT-hook DNA binding motif containing 1 | Dažnai (30–79%) | 1 ligoje |
| ALDH18A1aldehyde dehydrogenase 18 family member A1 | Dažnai (30–79%) | 2 ligose |
| AMHanti-Mullerian hormone | Dažnai (30–79%) | 2 ligose |
| AMHR2anti-Mullerian hormone receptor type 2 | Dažnai (30–79%) | 2 ligose |
| ARID1AAT-rich interaction domain 1A | Dažnai (30–79%) | 1 ligoje |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Dažnai (30–79%) | 1 ligoje |
| ATP6V1AATPase H+ transporting V1 subunit A | Dažnai (30–79%) | 2 ligose |
| ATP6V1E1ATPase H+ transporting V1 subunit E1 | Dažnai (30–79%) | 1 ligoje |
| BAZ1Bbromodomain adjacent to zinc finger domain 1B | Dažnai (30–79%) | 1 ligoje |
| BUB1BUB1 mitotic checkpoint serine/threonine kinase | Dažnai (30–79%) | 1 ligoje |
| BUD23BUD23 rRNA methyltransferase and ribosome maturation factor | Dažnai (30–79%) | 1 ligoje |
| CLDN19claudin 19 | Dažnai (30–79%) | 1 ligoje |
| CLIP2CAP-Gly domain containing linker protein 2 | Dažnai (30–79%) | 1 ligoje |
| COL1A1collagen type I alpha 1 chain | Dažnai (30–79%) | 3 ligose |
| COL1A2collagen type I alpha 2 chain | Dažnai (30–79%) | 3 ligose |
| COX11cytochrome c oxidase copper chaperone COX11 | Dažnai (30–79%) | 1 ligoje |
| DICER1dicer 1, ribonuclease III | Dažnai (30–79%) | 1 ligoje |
| DLK1delta like non-canonical Notch ligand 1 | Dažnai (30–79%) | 1 ligoje |
| DLX4distal-less homeobox 4 | Dažnai (30–79%) | 1 ligoje |
| DNAJC30DnaJ heat shock protein family (Hsp40) member C30 | Dažnai (30–79%) | 1 ligoje |
| DPP9dipeptidyl peptidase 9 | Dažnai (30–79%) | 1 ligoje |
| EIF4Heukaryotic translation initiation factor 4H | Dažnai (30–79%) | 1 ligoje |
| ELNelastin | Dažnai (30–79%) | 5 ligose |
| ELOVL4ELOVL fatty acid elongase 4 | Dažnai (30–79%) | 1 ligoje |
| EZH2enhancer of zeste 2 polycomb repressive complex 2 subunit | Dažnai (30–79%) | 2 ligose |
| FAAP100FA core complex associated protein 100 | Dažnai (30–79%) | 1 ligoje |
| FBLN5fibulin 5 | Dažnai (30–79%) | 3 ligose |
| FBN1fibrillin 1 | Dažnai (30–79%) | 2 ligose |
| FEM1Bfem-1 homolog B | Dažnai (30–79%) | 1 ligoje |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Dažnai (30–79%) | 2 ligose |
| FKBP6FKBP prolyl isomerase family member 6 (inactive) | Dažnai (30–79%) | 1 ligoje |
| FOCADfocadhesin | Dažnai (30–79%) | 1 ligoje |
| GDF11growth differentiation factor 11 | Dažnai (30–79%) | 1 ligoje |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Dažnai (30–79%) | 3 ligose |
| GNSglucosamine (N-acetyl)-6-sulfatase | Dažnai (30–79%) | 1 ligoje |
| GPC3glypican 3 | Dažnai (30–79%) | 2 ligose |
| GPC4glypican 4 | Dažnai (30–79%) | 1 ligoje |
| GTF2Igeneral transcription factor IIi | Dažnai (30–79%) | 1 ligoje |
| GTF2IRD1GTF2I repeat domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| GTF2IRD2GTF2I repeat domain containing 2 | Dažnai (30–79%) | 1 ligoje |
| HOXC13homeobox C13 | Dažnai (30–79%) | 1 ligoje |
| HSD17B3hydroxysteroid 17-beta dehydrogenase 3 | Dažnai (30–79%) | 1 ligoje |
| IFT122intraflagellar transport 122 | Dažnai (30–79%) | 1 ligoje |
| IFT140intraflagellar transport 140 | Dažnai (30–79%) | 1 ligoje |
| IFT56intraflagellar transport 56 | Dažnai (30–79%) | 1 ligoje |
| IPO8importin 8 | Dažnai (30–79%) | 1 ligoje |
| ISL1ISL LIM homeobox 1 | Dažnai (30–79%) | 1 ligoje |
| KDM5Blysine demethylase 5B | Dažnai (30–79%) | 1 ligoje |
| KIF7kinesin family member 7 | Dažnai (30–79%) | 3 ligose |
| LIMK1LIM domain kinase 1 | Dažnai (30–79%) | 1 ligoje |
| LTBP1latent transforming growth factor beta binding protein 1 | Dažnai (30–79%) | 2 ligose |
| LTBP4latent transforming growth factor beta binding protein 4 | Dažnai (30–79%) | 1 ligoje |
| MDFICMyoD family inhibitor domain containing | Dažnai (30–79%) | 1 ligoje |
| MED12mediator complex subunit 12 | Dažnai (30–79%) | 3 ligose |
| MEG3maternally expressed 3 | Dažnai (30–79%) | 1 ligoje |
| METTL27methyltransferase like 27 | Dažnai (30–79%) | 1 ligoje |
| MTFMTmitochondrial methionyl-tRNA formyltransferase | Dažnai (30–79%) | 1 ligoje |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Dažnai (30–79%) | 2 ligose |
| NALCNsodium leak channel, non-selective | Dažnai (30–79%) | 1 ligoje |
| NCF1neutrophil cytosolic factor 1 | Dažnai (30–79%) | 1 ligoje |
| NOTCH3notch receptor 3 | Dažnai (30–79%) | 2 ligose |
| NSD1nuclear receptor binding SET domain protein 1 | Dažnai (30–79%) | 2 ligose |
| OFD1OFD1 centriole and centriolar satellite protein | Dažnai (30–79%) | 1 ligoje |
| PIEZO2piezo type mechanosensitive ion channel component 2 | Dažnai (30–79%) | 2 ligose |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Dažnai (30–79%) | 1 ligoje |
| PIGYphosphatidylinositol glycan anchor biosynthesis class Y | Dažnai (30–79%) | 1 ligoje |
| PTDSS1phosphatidylserine synthase 1 | Dažnai (30–79%) | 2 ligose |
| RAB3GAP2RAB3 GTPase activating non-catalytic protein subunit 2 | Dažnai (30–79%) | 1 ligoje |
| RFC2replication factor C subunit 2 | Dažnai (30–79%) | 1 ligoje |
| RIPK4receptor interacting serine/threonine kinase 4 | Dažnai (30–79%) | 1 ligoje |
| RNF13ring finger protein 13 | Dažnai (30–79%) | 2 ligose |
| RPL10ribosomal protein L10 | Dažnai (30–79%) | 2 ligose |
| RTL1retrotransposon Gag like 1 | Dažnai (30–79%) | 1 ligoje |
| SEC31ASEC31 homolog A, COPII component | Dažnai (30–79%) | 1 ligoje |
| SGSHN-sulfoglucosamine sulfohydrolase | Dažnai (30–79%) | 1 ligoje |
| SHPKsedoheptulokinase | Dažnai (30–79%) | 1 ligoje |
| SKISKI proto-oncogene | Dažnai (30–79%) | 2 ligose |
| SLC10A7solute carrier family 10 member 7 | Dažnai (30–79%) | 1 ligoje |
| SLC2A10solute carrier family 2 member 10 | Dažnai (30–79%) | 2 ligose |
| SLC5A6solute carrier family 5 member 6 | Dažnai (30–79%) | 1 ligoje |
| SMAD2SMAD family member 2 | Dažnai (30–79%) | 2 ligose |
| SMAD3SMAD family member 3 | Dažnai (30–79%) | 3 ligose |
| SMARCA2SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 | Dažnai (30–79%) | 1 ligoje |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Dažnai (30–79%) | 1 ligoje |
| STX1Asyntaxin 1A | Dažnai (30–79%) | 1 ligoje |
| SUZ12SUZ12 polycomb repressive complex 2 subunit | Dažnai (30–79%) | 1 ligoje |
| TBL2transducin beta like 2 | Dažnai (30–79%) | 1 ligoje |
| TGFB2transforming growth factor beta 2 | Dažnai (30–79%) | 2 ligose |
| TMEM270transmembrane protein 270 | Dažnai (30–79%) | 1 ligoje |
| TP63tumor protein p63 | Dažnai (30–79%) | 1 ligoje |
| VPS37DVPS37D subunit of ESCRT-I | Dažnai (30–79%) | 1 ligoje |
| ZEB1zinc finger E-box binding homeobox 1 | Dažnai (30–79%) | 1 ligoje |
| ZFXzinc finger protein X-linked | Dažnai (30–79%) | 1 ligoje |
| ACTA2actin alpha 2, smooth muscle | Kartais (5–29%) | 1 ligoje |
| AGAaspartylglucosaminidase | Kartais (5–29%) | 1 ligoje |
| ARPC4actin related protein 2/3 complex subunit 4 | Kartais (5–29%) | 1 ligoje |
| ARSBarylsulfatase B | Kartais (5–29%) | 1 ligoje |
| ARVCFARVCF delta catenin family member | Kartais (5–29%) | 1 ligoje |
| ARXaristaless related homeobox | Kartais (5–29%) | 1 ligoje |
| AUTS2activator of transcription and developmental regulator AUTS2 | Kartais (5–29%) | 2 ligose |
| B3GAT3beta-1,3-glucuronyltransferase 3 | Kartais (5–29%) | 1 ligoje |
| B3GLCTbeta 3-glucosyltransferase | Kartais (5–29%) | 1 ligoje |
| BCL11ABCL11 transcription factor A | Kartais (5–29%) | 1 ligoje |
| BCRBCR activator of RhoGEF and GTPase | Kartais (5–29%) | 1 ligoje |
| BRF1BRF1 general transcription factor IIIB subunit | Kartais (5–29%) | 1 ligoje |
| BRPF1bromodomain and PHD finger containing 1 | Kartais (5–29%) | 1 ligoje |
| CC2D2Acoiled-coil and C2 domain containing 2A | Kartais (5–29%) | 1 ligoje |
| CCDC22CCC complex scaffolding subunit CCDC22 | Kartais (5–29%) | 1 ligoje |
| CDC42cell division cycle 42 | Kartais (5–29%) | 2 ligose |
| CDKN1Ccyclin dependent kinase inhibitor 1C | Kartais (5–29%) | 1 ligoje |
| CHD3chromodomain helicase DNA binding protein 3 | Kartais (5–29%) | 1 ligoje |
| CHRNGcholinergic receptor nicotinic gamma subunit | Kartais (5–29%) | 2 ligose |
| CHST3carbohydrate sulfotransferase 3 | Kartais (5–29%) | 1 ligoje |
| COL5A1collagen type V alpha 1 chain | Kartais (5–29%) | 2 ligose |
| COL5A2collagen type V alpha 2 chain | Kartais (5–29%) | 1 ligoje |
| COMTcatechol-O-methyltransferase | Kartais (5–29%) | 1 ligoje |
| CREBBPCREB binding lysine acetyltransferase | Kartais (5–29%) | 2 ligose |
| CRELD1CRELD disulfide isomerase 1 | Kartais (5–29%) | 1 ligoje |
| CRKLCRK like proto-oncogene, adaptor protein | Kartais (5–29%) | 1 ligoje |
| CSNK2A1casein kinase 2 alpha 1 | Kartais (5–29%) | 1 ligoje |
| CTCFCCCTC-binding factor | Kartais (5–29%) | 1 ligoje |
| CTNND2catenin delta 2 | Kartais (5–29%) | 1 ligoje |
| CWC27CWC27 spliceosome associated cyclophilin | Kartais (5–29%) | 1 ligoje |
| DGCR2DiGeorge syndrome critical region gene 2 | Kartais (5–29%) | 1 ligoje |
| DGCR6DiGeorge syndrome critical region gene 6 | Kartais (5–29%) | 1 ligoje |
| DGCR8DGCR8 microprocessor complex subunit | Kartais (5–29%) | 1 ligoje |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Kartais (5–29%) | 1 ligoje |
| DLL3delta like canonical Notch ligand 3 | Kartais (5–29%) | 1 ligoje |
| DPH1diphthamide biosynthesis 1 | Kartais (5–29%) | 1 ligoje |
| DPH2diphthamide biosynthesis 2 | Kartais (5–29%) | 1 ligoje |
| DPYSL5dihydropyrimidinase like 5 | Kartais (5–29%) | 1 ligoje |
| DVL1dishevelled segment polarity protein 1 | Kartais (5–29%) | 2 ligose |
| DVL3dishevelled segment polarity protein 3 | Kartais (5–29%) | 1 ligoje |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Kartais (5–29%) | 1 ligoje |
| EHMT1euchromatic histone lysine methyltransferase 1 | Kartais (5–29%) | 3 ligose |
| EMILIN1elastin microfibril interfacer 1 | Kartais (5–29%) | 1 ligoje |
| ESS2ess-2 spliceosome associated protein | Kartais (5–29%) | 1 ligoje |
| FANCBFA complementation group B | Kartais (5–29%) | 1 ligoje |
| FBXW11F-box and WD repeat domain containing 11 | Kartais (5–29%) | 1 ligoje |
| FGFR1fibroblast growth factor receptor 1 | Kartais (5–29%) | 2 ligose |
| FKBP14FKBP prolyl isomerase 14 | Kartais (5–29%) | 1 ligoje |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Kartais (5–29%) | 1 ligoje |
| FOXE3forkhead box E3 | Kartais (5–29%) | 1 ligoje |
| FZD2frizzled class receptor 2 | Kartais (5–29%) | 1 ligoje |
| G6PC3glucose-6-phosphatase catalytic subunit 3 | Kartais (5–29%) | 1 ligoje |
| GATA6GATA binding protein 6 | Kartais (5–29%) | 1 ligoje |
| GDF1growth differentiation factor 1 | Kartais (5–29%) | 1 ligoje |
| GLI3GLI family zinc finger 3 | Kartais (5–29%) | 3 ligose |
| GNB2G protein subunit beta 2 | Kartais (5–29%) | 1 ligoje |
| GP1BBglycoprotein Ib platelet subunit beta | Kartais (5–29%) | 1 ligoje |
| GRIN2Bglutamate ionotropic receptor NMDA type subunit 2B | Kartais (5–29%) | 1 ligoje |
| GZF1GDNF inducible zinc finger protein 1 | Kartais (5–29%) | 1 ligoje |
| H19H19 imprinted maternally expressed transcript | Kartais (5–29%) | 1 ligoje |
| HES7hes family bHLH transcription factor 7 | Kartais (5–29%) | 1 ligoje |
| HEY2hes related family bHLH transcription factor with YRPW motif 2 | Kartais (5–29%) | 1 ligoje |
| HIRAhistone cell cycle regulator | Kartais (5–29%) | 1 ligoje |
| HMGA2high mobility group AT-hook 2 | Kartais (5–29%) | 1 ligoje |
| HSPG2heparan sulfate proteoglycan 2 | Kartais (5–29%) | 2 ligose |
| IGF2insulin like growth factor 2 | Kartais (5–29%) | 2 ligose |
| INPP5Einositol polyphosphate-5-phosphatase E | Kartais (5–29%) | 1 ligoje |
| JMJD1Cjumonji domain containing 1C | Kartais (5–29%) | 1 ligoje |
| KCNQ1OT1KCNQ1 opposite strand/antisense transcript 1 | Kartais (5–29%) | 1 ligoje |
| KDM3Blysine demethylase 3B | Kartais (5–29%) | 1 ligoje |
| KMT2Clysine methyltransferase 2C | Kartais (5–29%) | 1 ligoje |
| LFNGLFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | Kartais (5–29%) | 1 ligoje |
| LOXlysyl oxidase | Kartais (5–29%) | 1 ligoje |
| LRPPRCleucine rich pentatricopeptide repeat containing | Kartais (5–29%) | 1 ligoje |
| MAFMAF bZIP transcription factor | Kartais (5–29%) | 1 ligoje |
| MAPK1mitogen-activated protein kinase 1 | Kartais (5–29%) | 1 ligoje |
| MAPRE2microtubule associated protein RP/EB family member 2 | Kartais (5–29%) | 1 ligoje |
| MAT2Amethionine adenosyltransferase 2A | Kartais (5–29%) | 1 ligoje |
| MBTPS2membrane bound transcription factor peptidase, site 2 | Kartais (5–29%) | 2 ligose |
| MED25mediator complex subunit 25 | Kartais (5–29%) | 2 ligose |
| MEIS2Meis homeobox 2 | Kartais (5–29%) | 1 ligoje |
| MESP2mesoderm posterior bHLH transcription factor 2 | Kartais (5–29%) | 1 ligoje |
| MFAP5microfibril associated protein 5 | Kartais (5–29%) | 1 ligoje |
| MID1midline 1 | Kartais (5–29%) | 2 ligose |
| MLXIPLMLX interacting protein like | Kartais (5–29%) | 1 ligoje |
| MSL2MSL complex subunit 2 | Kartais (5–29%) | 1 ligoje |
| MYH11myosin heavy chain 11 | Kartais (5–29%) | 1 ligoje |
| MYH3myosin heavy chain 3 | Kartais (5–29%) | 3 ligose |
| MYLKmyosin light chain kinase | Kartais (5–29%) | 1 ligoje |
| NEU1neuraminidase 1 | Kartais (5–29%) | 3 ligose |
| NIPBLNIPBL cohesin loading factor | Kartais (5–29%) | 1 ligoje |
| NOTCH1notch receptor 1 | Kartais (5–29%) | 1 ligoje |
| NOTCH2notch receptor 2 | Kartais (5–29%) | 2 ligose |
| NPHP3nephrocystin 3 | Kartais (5–29%) | 1 ligoje |
| NXNnucleoredoxin | Kartais (5–29%) | 1 ligoje |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Kartais (5–29%) | 1 ligoje |
| ODC1ornithine decarboxylase 1 | Kartais (5–29%) | 1 ligoje |
| P3H1prolyl 3-hydroxylase 1 | Kartais (5–29%) | 1 ligoje |
| PACS1phosphofurin acidic cluster sorting protein 1 | Kartais (5–29%) | 1 ligoje |
| PAFAH1B1platelet activating factor acetylhydrolase 1b regulatory subunit 1 | Kartais (5–29%) | 1 ligoje |
| PHGDHphosphoglycerate dehydrogenase | Kartais (5–29%) | 1 ligoje |
| PIGSphosphatidylinositol glycan anchor biosynthesis class S | Kartais (5–29%) | 1 ligoje |
| PLAG1PLAG1 zinc finger | Kartais (5–29%) | 1 ligoje |
| PLOD1procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | Kartais (5–29%) | 2 ligose |
| POGZpogo transposable element derived with ZNF domain | Kartais (5–29%) | 2 ligose |
| POLR2ARNA polymerase II subunit A | Kartais (5–29%) | 1 ligoje |
| PORCNporcupine O-acyltransferase | Kartais (5–29%) | 2 ligose |
| PPP2CAprotein phosphatase 2 catalytic subunit alpha | Kartais (5–29%) | 1 ligoje |
| PPP2R1Aprotein phosphatase 2 scaffold subunit Aalpha | Kartais (5–29%) | 1 ligoje |
| PRDM5PR/SET domain 5 | Kartais (5–29%) | 1 ligoje |
| PRKG1protein kinase cGMP-dependent 1 | Kartais (5–29%) | 1 ligoje |
| PUF60poly(U) binding splicing factor 60 | Kartais (5–29%) | 1 ligoje |
| RAP1BRAP1B, member of RAS oncogene family | Kartais (5–29%) | 1 ligoje |
| RELREL proto-oncogene, NF-kB subunit | Kartais (5–29%) | 1 ligoje |
| RIC1RIC1 partner of RAB6A GEF complex | Kartais (5–29%) | 1 ligoje |
| RIPPLY2ripply transcriptional repressor 2 | Kartais (5–29%) | 1 ligoje |
| RNU4-2RNA, U4 small nuclear 2 | Kartais (5–29%) | 1 ligoje |
| ROR2ROR family WNT receptor 2 | Kartais (5–29%) | 2 ligose |
| RPGRIP1LRPGRIP1 like | Kartais (5–29%) | 1 ligoje |
| RPL17ribosomal protein L17 | Kartais (5–29%) | 1 ligoje |
| RPS6KA3ribosomal protein S6 kinase A3 | Kartais (5–29%) | 2 ligose |
| RREB1ras responsive element binding protein 1 | Kartais (5–29%) | 1 ligoje |
| SEC24CSEC24 homolog C, COPII component | Kartais (5–29%) | 1 ligoje |
| SEMA5Asemaphorin 5A | Kartais (5–29%) | 1 ligoje |
| SETSET nuclear proto-oncogene | Kartais (5–29%) | 1 ligoje |
| SETD5SET domain containing 5 | Kartais (5–29%) | 1 ligoje |
| SH3PXD2BSH3 and PX domains 2B | Kartais (5–29%) | 1 ligoje |
| SHOC2SHOC2 leucine rich repeat scaffold protein | Kartais (5–29%) | 1 ligoje |
| SMAD4SMAD family member 4 | Kartais (5–29%) | 2 ligose |
| SMARCC2SWI/SNF related BAF chromatin remodeling complex subunit C2 | Kartais (5–29%) | 1 ligoje |
| SRCAPSnf2 related CREBBP activator protein | Kartais (5–29%) | 1 ligoje |
| TASP1taspase 1 | Kartais (5–29%) | 1 ligoje |
| TBX1T-box transcription factor 1 | Kartais (5–29%) | 3 ligose |
| TBX6T-box transcription factor 6 | Kartais (5–29%) | 1 ligoje |
| TGFB3transforming growth factor beta 3 | Kartais (5–29%) | 2 ligose |
| THSD4thrombospondin type 1 domain containing 4 | Kartais (5–29%) | 1 ligoje |
| TMEM67transmembrane protein 67 | Kartais (5–29%) | 1 ligoje |
| TNRC6Btrinucleotide repeat containing adaptor 6B | Kartais (5–29%) | 1 ligoje |
| TRAF7TNF receptor associated factor 7 | Kartais (5–29%) | 1 ligoje |
| TRIM33tripartite motif containing 33 | Kartais (5–29%) | 1 ligoje |
| TRPV6transient receptor potential cation channel subfamily V member 6 | Kartais (5–29%) | 1 ligoje |
| TUBBtubulin beta class I | Kartais (5–29%) | 1 ligoje |
| TXNL4Athioredoxin like 4A | Kartais (5–29%) | 1 ligoje |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Kartais (5–29%) | 1 ligoje |
| VPS35LVPS35 endosomal protein sorting factor like | Kartais (5–29%) | 1 ligoje |
| WASHC5WASH complex subunit 5 | Kartais (5–29%) | 1 ligoje |
| WNT5AWnt family member 5A | Kartais (5–29%) | 2 ligose |
| XPO1exportin 1 | Kartais (5–29%) | 1 ligoje |
| YWHAEtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | Kartais (5–29%) | 1 ligoje |
| ADNPactivity dependent neuroprotector homeobox | Retai (1–4 %) | 1 ligoje |
| APC2APC regulator of Wnt signaling pathway 2 | Retai (1–4 %) | 1 ligoje |
| CHST14carbohydrate sulfotransferase 14 | Retai (1–4 %) | 1 ligoje |
| CLCN4Cl-/H+ antiporter 4 | Retai (1–4 %) | 1 ligoje |
| SETBP1SET binding protein 1 | Retai (1–4 %) | 1 ligoje |
| SKIC2SKI2 subunit of superkiller complex | Retai (1–4 %) | 1 ligoje |
| SKIC3SKI3 subunit of superkiller complex | Retai (1–4 %) | 1 ligoje |
| TRRAPtransformation/transcription domain associated protein | Retai (1–4 %) | 1 ligoje |
| ADAMTS2ADAM metallopeptidase with thrombospondin type 1 motif 2 | Neužfiksuota | 1 ligoje |
| ARandrogen receptor | Neužfiksuota | 1 ligoje |
| ARID1BAT-rich interaction domain 1B | Neužfiksuota | 1 ligoje |
| ASPNATaspartate N-acetyltransferase | Neužfiksuota | 1 ligoje |
| BMPERBMP binding endothelial regulator | Neužfiksuota | 1 ligoje |
| BRAT1BRCA1 associated ATM activator 1 | Neužfiksuota | 1 ligoje |
| C1Rcomplement C1r | Neužfiksuota | 1 ligoje |
| C1Scomplement C1s | Neužfiksuota | 1 ligoje |
| CBScystathionine beta-synthase | Neužfiksuota | 1 ligoje |
| COL2A1collagen type II alpha 1 chain | Neužfiksuota | 2 ligose |
| DDX6DEAD-box helicase 6 | Neužfiksuota | 1 ligoje |
| FLNBfilamin B | Neužfiksuota | 1 ligoje |
| GALNSgalactosamine (N-acetyl)-6-sulfatase | Neužfiksuota | 1 ligoje |
| GLB1galactosidase beta 1 | Neužfiksuota | 2 ligose |
| GLRA1glycine receptor alpha 1 | Neužfiksuota | 1 ligoje |
| GNEglucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Neužfiksuota | 1 ligoje |
| GPHNgephyrin | Neužfiksuota | 1 ligoje |
| IDSiduronate 2-sulfatase | Neužfiksuota | 1 ligoje |
| LDHDlactate dehydrogenase D | Neužfiksuota | 1 ligoje |
| MAN2B1mannosidase alpha class 2B member 1 | Neužfiksuota | 1 ligoje |
| NFIAnuclear factor I A | Neužfiksuota | 1 ligoje |
| PLD1phospholipase D1 | Neužfiksuota | 1 ligoje |
| PLOD2procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 | Neužfiksuota | 1 ligoje |
| SATB2SATB homeobox 2 | Neužfiksuota | 1 ligoje |
| SIN3ASIN3 transcription regulator family member A | Neužfiksuota | 1 ligoje |
| SLC26A2solute carrier family 26 member 2 | Neužfiksuota | 1 ligoje |
| STRA6signaling receptor and transporter of retinol STRA6 | Neužfiksuota | 1 ligoje |
| TBX3T-box transcription factor 3 | Neužfiksuota | 1 ligoje |
| TGDSTDP-glucose 4,6-dehydratase | Neužfiksuota | 1 ligoje |
| TMCO1transmembrane and coiled-coil domains 1 | Neužfiksuota | 1 ligoje |
| TMEM70transmembrane protein 70 | Neužfiksuota | 1 ligoje |
| UBA1ubiquitin like modifier activating enzyme 1 | Neužfiksuota | 1 ligoje |
| WNK3WNK lysine deficient protein kinase 3 | Neužfiksuota | 1 ligoje |
| XRCC4X-ray repair cross complementing 4 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites